Patent ID: 8909483

Claim:
A direct or indirect diagnostic test for helminth infection using peptide fragments as an active ingredient, wherein the peptide fragments have similar or conservatively substituted amino acid sequences to those found in epitopic portions of the Sm14antigen or a related Fatty Acid Binding Protein (FABP) from heiminth pathogens, said peptide fragments obtained by a method consisting of: (i) selecting a region of a parent protein that contains residues that are spatially close in the three-dimensional structure but distant in the amino acid sequence and which form discontinuous epitopes; (ii) giving priority to maintaining epitopic residues predicted to be responsible for stimulating the desired immuno/antigenic response, within the selected peptide sequence; (iii) elaborating sequences which are of limited size varying from 8 to 28 residues and which maintain at least some of the previously predicted epitopic residues; (iv) choosing at least two peptides from the elaborated sequences that correspond to regions that are distant in the primary structure (amino acid sequence) but spatially close in the tertiary (three-dimensional) structure of the parent protein, wherein said regions are chosen on the basis that the three-dimensional structure indicates that they can be readily fused assuming that they retain their original structures; and (v) constructing the fusion peptide molecule comprising the chosen at least two peptides in step (iv).